Tech Company Inital Public Offerings
Flex Pharma IPO
Flex Pharma, operating out of Boston, debuted as a public company on 1/29/2015.
Transaction Overview
Company Name
Announced On
1/29/2015
Transaction Type
IPO
Amount
$86,400,000
Proceeds Purpose
Proceeds purposes are on file with company statements at the SEC.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
800 Boylston St.
Boston, MA 02199
USA
Boston, MA 02199
USA
Phone
Website
Email Address
Overview
Flex Pharma, Inc. develops clinically proven products and treatments for muscle cramps and spasms.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William McVicar
Chief Financial Officer
John McCabe
Chief Medical Officer
Thomas Wessel
Vice President
Elizabeth Woo
VP - Bus. Development
Angelene Simonello
VP - Operations
David Golod
VP - R & D
Glenn Short
Browse more venture capital transactions:
Prev: 1/29/2015: Bench venture capital transaction
Next: 1/29/2015: Witkit venture capital transaction
Share this article
About Database of VC Transactions
We report on all VC transactions involving tech companies. VC investment data records on this site are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs